Recent Finacing
Recent Raise
Treeline is a clinical-stage biopharma developing oncology and neurological/autoimmune therapies via internal R&D and computational drug discovery, advancing small molecules, protein degraders and glues, TT‑ADCs and Phase 1 programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
